Because NSG mice lack a homeostatic IL2/15R ligand required to support NK-cell survival and expansion, IL2 (50,000 IU/mouse) was injected every other day (intraperitoneally) to support transferred human NK cells (21) and the melanoma burden was monitored by BLI weekly (Fig. 5A). Here, IL2 is linked to melanoma.